At-home OCT enables daily monitoring of patients with neovasular age-related macular degeneration (AMD) and other patients that need a lot of follow-ups.

With host Carey Powers, Dr. Anat Loewenstein dives into at-home OCT innovation, application, and adoption.

Dr. Loewenstein is Head of the Department of Ophthalmology and Vice Dean at Tel Aviv Medical Center. She’s also a fellowship-trained vitreoretinal surgeon and has been heavily involved in research related to early AMD detection.

Why all the fuss about at-home OCT? An at-home monitoring solution will potentially lessen the number of appointments for patients who don’t need them. More-frequent monitoring could also help catch disease changes sooner so doctors can facilitate treatment asap.

Listen to the podcast today to discover:

• How at-home OCT works and the role artificial intelligence (AI) plays in image analysis.
• The patient experience when using at-home OCT.
• How disease activity alerts are delivered from the at-home device to the physician.
• Once a physician receives an alert, steps to take to get the patient into the clinic right away.
• The status of products closest to FDA approval, such as Notal Home OCT from Notal Vision.
• Dr. Loewenstein’s thoughts on the global health implications of at-home OCT.

[Listen Now]

Resources

Anat Loewenstein: linkedin.com/in/anat-loewenstein-b48a595

Carey Powers: ois.net/carey-powers